Navigation Links
Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
Date:10/29/2012

SAN FRANCISCO, Oct. 29, 2012 /PRNewswire/ -- Principia Biopharma, Inc., a privately-held biopharmaceutical company focused on advancing best-in-class medicines in immunology, autoimmune diseases, and oncology announced that it successfully met its milestone obligations and received its second tranche of funding totaling $12.5 million in July 2012. The investment was led by existing investors New Leaf Venture Partners, OrbiMed Advisors, Morgenthaler Ventures, SROne and Mission Bay Capital.  In February 2011, Principia completed a tiered Series A round of financing totaling $36.3 million and received the first tranche of $12 million that same month.  Proceeds from this most recent financing will be used to advance Principia's lead molecule towards the clinic and to develop additional programs enabled by the company's reversible covalent platform.

(Logo: http://photos.prnewswire.com/prnh/20121029/NY01747LOGO)

Martin Babler, CEO of Principia, says, "We are pleased to complete the closing of our second tranche as it provides the necessary funding for Principia to advance our lead compound toward our first clinical trials in 2013. We appreciate the continued support from our current investors as we invest in important treatments for cancer and autoimmune disorders."

EXPANSION OF SENIOR MANAGEMENT TEAM

As part of Principia's growth and its initiatives to bring new medicines to patients, the company has expanded its senior management team with the hiring of Jens Oliver Funk, M.D. as Chief Scientific Officer (C
'/>"/>

SOURCE Principia Biopharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
2. Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
3. PDL BioPharma Completes Regular Quarterly Dividend Payment
4. Chester County Biopharmaceutical Firm to Expand, Create 151 New Jobs
5. National Press Club to Host "NEWSMAKER" with PhRMA CEO to Discuss Policy, Budget Threats to Biopharmaceutical Research
6. PDL BioPharma to Present at Upcoming Investor Conferences
7. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
8. The Thousand-Year Business Model for a Modern Biopharmaceutical Company
9. BioWorld Launches Enhanced Biopharma News Site with Data, Analysis
10. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
11. New Stroke Drug from ZZ Biotech Produced by Laureate Biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gbd3bt/stability_testing ) ... of Pharmaceuticals (London, UK - December 2-3, 2015)" ... comprehensive two day seminar delegates will: - ... suitable for global arketing - Be able to ... and facilities - Know how to save resource ...
(Date:9/3/2015)... Sept. 3, 2015 Report ... New Drugs, Industry Changes and Emerging Opportunities What,s ... ovaries? Visiongain,s new study forecasts those pharmaceutical revenues. ... that industry. You also explore trends, results, treatments, ... report gives revenue predictions to 2025 at overall ...
(Date:9/3/2015)... , Sept. 3, 2015 About self-monitoring ... is a home-based electronic device. It consists of ... information about glucose levels through radiowaves from the ... The regular usage of self-monitoring blood glucose devices ... individual to undergo proper diabetes treatment. ...
Breaking Medicine Technology:Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
... At the ARPA-E Energy Innovation Summit today in ... will announce significant progress towards developing economical, commercial scale ... plants.  The program is supported by an ARPA-E Recovery ... of carbon dioxide, a significant greenhouse gas. ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced ... for 2011 and beyond and declared that the four quarterly dividends ... per share of common stock.  The $0.15 dividends will be paid ... all stockholders who own shares of PDL on March 8, June ...
Cached Medicine Technology:Codexis Announces Carbon Capture Progress at ARPA-E Summit 2Codexis Announces Carbon Capture Progress at ARPA-E Summit 3PDL BioPharma Announces Regular Quarterly Dividend Policy 2
(Date:9/4/2015)... ... ... After wearing the same uniforms for six seasons, the Sprayberry High School girls ... the team, the Jones Agency, a locally owned insurance firm that serves communities in ... uniforms. , As is so often the case with high school and many school-related ...
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability ... of the Year” awards at this year’s Microsoft Worldwide Partner Conference that was ... of the Year” Award Winner for Data Platform services, the 2015 HP and ...
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the daily stressors and distractions ... and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons ... the island’s only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel ...
(Date:9/4/2015)... Grants Pass, OR (PRWEB) , ... September 04, ... ... Center that markets a line of personal humidifying medical devices, announced its only ... global climate, explains Bio-Logic Aqua® Research Founder Sharon Kleyne, body water evaporation is ...
(Date:9/4/2015)... ... ... access to a doctor can sometimes be a challenge for a variety of reasons. ... affects hospitals’ abilities to provide quality service to those with serious needs, increases insurance ... has recently presented itself, the new telemedicine platform and app, DocChat . ...
Breaking Medicine News(10 mins):Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3
... and the American Society of Hematology (ASH) are ... hematology training program, at,Mulago Hospital located in Kampala, ... as Uganda,s national referral, teaching, and research,hospital and ... of,this program is to improve the hematology training ...
... German . , Boxing is possibly less dangerous ... amateurs. However, conclusive statements on the level of danger are ... contracted their later brain conditions in his case Parkinsons ... remains unclear. The all-clear cannot be given until more extensive ...
... VANCOUVER, March 28 /PRNewswire-FirstCall/ - QLT Inc. ... from an investigator-sponsored Phase,II study, in patients ... macular degeneration (AMD), showed that a,combination therapy ... by half, the number of treatments required ...
... willingness to try technology like sensors,to detect falls ... cost, perception, and technical issues remain challenges, ... technology so they can age safely in their ... of the challenges of caregiving.,Concerns such as cost ...
... SYK ) announced that it will host a conference ... Time, to discuss the,Company,s operating results for the quarter ... results for the quarter ended,March 31, 2008 will be ... MacMillan, President and Chief Executive Officer, Dean H.,Bergy, Vice ...
... Joining the ranks of Australias most esteemed scientists is Professor ... has just been elected as a Fellow of the Australian ... Stanley are also among only 400 Australians to have been ... of just 16 scientists elected this year. , Professor ...
Cached Medicine News:Health News:HVO Launches Hematology Program in Uganda in Partnership with ASH 2Health News:How dangerous is boxing for the brain? 2Health News:Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference 2Health News:Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference 3Health News:Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference 4Health News:Older People Want to Use Technology to Help Them Remain at Home 2Health News:Older People Want to Use Technology to Help Them Remain at Home 3Health News:Older People Want to Use Technology to Help Them Remain at Home 4Health News:Stryker to Host Conference Call on April 17, 2008 2Health News:National recognition for top scientist 2
... 48-capillary 3730 DNA Analyzer, upgradeable to 96 ... DNA analysis. , Higher optical sensitivity ... higher-quality data at a lower cost. , ... , Optimized polymers increase your productivity without ...
... this unique offer, you can ... application. Pipetman P2 and P10 ... reagents, and P100 is perfect ... Filter Tips, which are especially ...
... is an immunochromatography based one step ... qualitative determination of Methamphetamine in human ... 1000 ng/mL. This assay has not ... care,location and is for use by ...
... The RapidAMP test is an ... test. It is,designed for qualitative determination ... above,a cut-off level of 1000 ng/mL. ... in the point of care,location and ...
Medicine Products: